Cargando…
The changes of subtype markers between first and second primary breast cancers
BACKGROUND: Previous studies investigated the changes of subtype markers [estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2)] in several clinical settings, but not for second primary breast cancer (SPBC) after first primary breast cancer (FPBC). M...
Autores principales: | Li, Chenyang, Lyu, Zhangyan, Wang, Zhipeng, Hao, Chunfang, Huang, Yubei, Song, Fengju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315743/ https://www.ncbi.nlm.nih.gov/pubmed/37096879 http://dx.doi.org/10.1002/cam4.5979 |
Ejemplares similares
-
Comparisons of clinical characteristics, prognosis, epidemiological factors, and genetic susceptibility between HER2‐low and HER2‐zero breast cancer among Chinese females
por: Zheng, Lu, et al.
Publicado: (2023) -
Development and evaluation of the screening performance of a low-cost high-risk screening strategy for breast cancer
por: Huang, Yubei, et al.
Publicado: (2022) -
Comparison of breast cancer risk factors among molecular subtypes: A case‐only study
por: Zhang, Liwen, et al.
Publicado: (2019) -
Associations of chest X-ray trajectories, smoking, and the risk of lung cancer in two population-based cohort studies
por: Liu, Ya, et al.
Publicado: (2023) -
Cohort profile: design and methods of the Chinese colorectal, breast, lung, liver, and stomach cancer screening trial (C-BLAST)
por: Huang, Yubei, et al.
Publicado: (2023)